Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2007-01-02
2007-01-02
Page, Thurman K. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
C560S170000, C562S433000, C423S407000
Reexamination Certificate
active
10092004
ABSTRACT:
The present invention provides compounds which inhibit serine protease activity of matriptase or MTSP1. Also provided are pharmaceutical compositions comprising those compounds and methods of using the compounds and pharmaceutical compositions to treat conditions ameliorated by inhibition of matriptase or MTSP1.
REFERENCES:
patent: 5492895 (1996-02-01), Vlasuk et al.
patent: 5534498 (1996-07-01), Brunck et al.
patent: 5646195 (1997-07-01), Mobley
patent: 5658939 (1997-08-01), Abelman et al.
patent: 5681844 (1997-10-01), Abelman et al.
patent: 5696231 (1997-12-01), Abelman et al.
patent: 5703208 (1997-12-01), Semple et al.
patent: 5714499 (1998-02-01), Semple et al.
patent: 5731413 (1998-03-01), Webb et al.
patent: 5739112 (1998-04-01), Brunck et al.
patent: 5770600 (1998-06-01), Abelman et al.
patent: 5775927 (1998-07-01), Wider
patent: 5883077 (1999-03-01), Brunck et al.
patent: 5886146 (1999-03-01), Vlasuk et al.
patent: 5955976 (1999-09-01), Heath
patent: 5972616 (1999-10-01), O'Brien et al.
patent: 6025472 (2000-02-01), Abelman et al.
patent: 6034215 (2000-03-01), Semple et al.
patent: 6797504 (2004-09-01), Madison et al.
patent: WO 00/05245 (2000-02-01), None
patent: WO 00/53232 (2000-09-01), None
patent: WO 01/29056 (2001-04-01), None
patent: WO 01/57194 (2001-08-01), None
patent: WO 01/97794 (2001-12-01), None
patent: WO 02/08392 (2002-01-01), None
Silverman, The Organic Chemistry of Drug Design and Drug Action, 1992, pp. 19 and 20.
Bock, P.E., et al., Isolation of human blood coagulation α-factor X8by soybean trypsin inhibitor—sepharose chromatography and its active-site titration with fluorescein mono-ρ-guanidinobenzoate1,Archives of Biochemistry and Biophysics,273(2): 375-388 (Sep. 1989).
Boring, C., Cancer Statistics, 1993,CA Cancer J. Clin.,43:7-26 (1993).
Brooks, P.C., et al., Use of the 10-day-old chick embryo model for studying angiogenesis,Methods in Molecular Biology,129:257-269 (1999).
Enyedy, I.J., et al., Structure-based approach for the discover of Bis-benzamidines as novel inhibitors of matriptase,J. Med. Chem.,44:1349-1355 (2001).
Hunter, T., Cooperation between oncogenes,Cell,64:249-270, (Jan. 25, 1991).
Land, H., et al., Cellular oncogenes and multistep carcinogenesis,Science222:771-778 (Nov. 18, 1983).
Lin, C., et al., Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity,The Journal of Biological Chemistry,274(26):18231-18236 (Jun. 25, 1999).
Lin, C., et al., Purification and characterization of a complex containing matriptase and a kunitz-type serine protease inhibitor from human milk,The Journal of Biological Chemistry,274(26):183237-18242 (Jun. 25, 1999).
McDonnell, S., et al., Stromelysin in tumor progression and metastasis,Cancer and Metastasis Reviews,9:305-319 (1980).
Mignatti, P., et al., Biology and biochemistry of proteinases in tumor invasion,Physiological Reviews,73(1):161-195 (Jan. 1993).
Ossowski, L, In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface—bound urokinase,The Journal of Cell Biology,107(No. 6 pt. 1):2437-2445 (Dec. 1988).
Ruly, H.E., Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture,Nature,304:602-606 (Aug. 18, 1993).
Takeuchi, T., et al., Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates,The Journal of Biological Chemistry,275(34):2633-26342 (Aug. 25, 2000).
Takeuchi, T., et al., Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue,Proc. Natl. Acad. Sci. USA,96:11054-11061 (Sep. 1999).
Tamura, S.Y., et al., Novel benzo-fused lactam scaffolds as factor Xa inhibitors,Bioorganic&Medicinal Chemistry Letters,9:2573-2578 (1999).
Seebach, D., et al., 107 .stereoselektive alkylierung an C(α) von serin, glycerinsäure, threomin und weinsaäure über heterocyclische enolate mit exocyclischer doppelbindung1)2),Helvetica Chimica Acta,70:1194-1216 (1987).
Araldi Gian Luca
Coombs Gary S.
Ong Edgar O
Reiner John E.
Semple Joseph E.
Dendreon Corporation
Hopkins Mark H.
Page Thurman K.
Puttlitz Karl
Snyder Joseph R.
LandOfFree
Inhibitors of serine protease activity of matriptase or MTSP1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of serine protease activity of matriptase or MTSP1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of serine protease activity of matriptase or MTSP1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3757207